Revance Therapeutics, Inc.
Albumin-Free Botulinum Toxin Formulations
Last updated:
Abstract:
This invention relates to botulinum toxin formulations that are stabilized without the use of any proteinaceous excipients. The invention also relates to methods of preparing and using such botulinum toxin formulations.
Status:
Application
Type:
Utility
Filling date:
18 May 2021
Issue date:
28 Oct 2021